COMP <GO>
UTMD vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY
Utah Medical Products Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: UTMD 4
— JNJ 6
■ METRIC PARITY
LAST: $68.08 (+1.91%) • MKT CAP: $212.7M
balance-sheet
—
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UTMD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UTMD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.10% | 67.90% | -10.80 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.90% | 25.50% | +1.40 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.8x | 18.5x | -7.70 | UTMD | /valuation <GO> |
| Free Cash Flow Yield | 6.73% | 2.97% | +3.76 | UTMD | /fcf-yield <GO> |
| Operating Margin | 29.60% | 34.70% | -5.10 | JNJ | /operating-margins <GO> |
| Net Profit Margin | — | 28.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -5.80% | 6.00% | -11.80 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.87% | 0.00% | +1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.2 | 62.1 | -34.90 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $212.7M | $662.49B | -$662.28B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UTMD REV | JNJ REV | UTMD GROSS % | JNJ GROSS % | UTMD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.5M | $94.19B | 57.1% | 67.9% | $14.3M | $19.70B |
| FY 2024 | $40.9M | $88.82B | 59.0% | 69.1% | $14.6M | $19.84B |
| FY 2023 | $50.2M | $85.16B | — | — | $22.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UTMD // BETA —
JNJ // BETA 1.08